1. Home
  2. PBYI vs SEVN Comparison

PBYI vs SEVN Comparison

Compare PBYI & SEVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PBYI
  • SEVN
  • Stock Information
  • Founded
  • PBYI 2010
  • SEVN 1986
  • Country
  • PBYI United States
  • SEVN United States
  • Employees
  • PBYI N/A
  • SEVN N/A
  • Industry
  • PBYI Biotechnology: Pharmaceutical Preparations
  • SEVN Real Estate Investment Trusts
  • Sector
  • PBYI Health Care
  • SEVN Real Estate
  • Exchange
  • PBYI Nasdaq
  • SEVN Nasdaq
  • Market Cap
  • PBYI 171.7M
  • SEVN 161.7M
  • IPO Year
  • PBYI N/A
  • SEVN N/A
  • Fundamental
  • Price
  • PBYI $4.56
  • SEVN $10.99
  • Analyst Decision
  • PBYI Strong Buy
  • SEVN Strong Buy
  • Analyst Count
  • PBYI 1
  • SEVN 2
  • Target Price
  • PBYI $7.00
  • SEVN $13.50
  • AVG Volume (30 Days)
  • PBYI 980.5K
  • SEVN 46.9K
  • Earning Date
  • PBYI 11-06-2025
  • SEVN 10-27-2025
  • Dividend Yield
  • PBYI N/A
  • SEVN 10.19%
  • EPS Growth
  • PBYI 434.29
  • SEVN N/A
  • EPS
  • PBYI 0.97
  • SEVN 1.04
  • Revenue
  • PBYI $238,062,000.00
  • SEVN $29,272,000.00
  • Revenue This Year
  • PBYI N/A
  • SEVN N/A
  • Revenue Next Year
  • PBYI N/A
  • SEVN N/A
  • P/E Ratio
  • PBYI $4.75
  • SEVN $10.55
  • Revenue Growth
  • PBYI 8.63
  • SEVN N/A
  • 52 Week Low
  • PBYI $2.25
  • SEVN $10.01
  • 52 Week High
  • PBYI $6.07
  • SEVN $14.66
  • Technical
  • Relative Strength Index (RSI)
  • PBYI 47.28
  • SEVN 57.12
  • Support Level
  • PBYI $4.93
  • SEVN $10.59
  • Resistance Level
  • PBYI $5.22
  • SEVN $10.95
  • Average True Range (ATR)
  • PBYI 0.32
  • SEVN 0.17
  • MACD
  • PBYI -0.10
  • SEVN 0.06
  • Stochastic Oscillator
  • PBYI 7.37
  • SEVN 100.00

About PBYI Puma Biotechnology Inc

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis resulting into apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.

About SEVN Seven Hills Realty Trust

Seven Hills Realty Trust is a real estate investment trust. The company is engaged in the business of originating and investing in floating rate first mortgage loans secured by the middle market and transitional commercial real estate. Its primary objective is to balance capital preservation with generating risk-adjusted returns.

Share on Social Networks: